Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Health Canada approves Strensiq for hypophosphatasia

Aug. 18, 2015

PhytoTech Medical completes acquisition of MMJ Bioscience

July 31, 2015

Health Canada clears Hydra to begin phase I study of HX-100

April 16, 2015

Novartis's LCZ-696 awarded priority review by Health Canada

March 13, 2015

PBI-4050 granted U.S. orphan drug status for IPF

Feb. 18, 2015

Health Canada updates Zelboraf labeling to advise of pancreatitis risk

Feb. 13, 2015

ProMetic receives clearance to start trial of PBI-4050 in metabolic-syndrome-associated diabetes

Jan. 29, 2015

Tekmira authorized to start phase I trial of RNAi therapeutic for HBV infection

Dec. 29, 2014

Health Canada clears Immunovaccine to conduct phase II trial of DPX-Survivac

Nov. 20, 2014

PBI-4050 cleared to commence trials in patients with diabetic kidney disease

Nov. 12, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.